An official website of the United States government
Home
Name
CAPIRI
Alternate names
XELIRI
Primary Site
Colorectal
Esophagus
Stomach
Histology
None
Radiation
None
Remarks
None
Drugs for CAPIRI
Name
Alternate Names
Camptosar
Camptosar Oral
Camptothecin-11
CPT 11
CPT-11
CPT11
U-101440E
Abbreviations
None
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
616348
Primary Site
Colorectal
head & neck
Non-small cell lung cancer (NSCLC)
pancreatic cancer
Small cell lung cancer (SCLC)
Histology
None
Remarks
Phase I (head & neck) Phase III SCLC pancreatic Topoisomerase I inhibitor. FDA approved use on colorectal cancer. Pharmacia.
Coding
This drug should be coded
Name
Alternate Names
Ro 091978
Ro-09-1978
Ro-091978
Xeloda
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
712807
Primary Site
Histology
None
Remarks
FDA approved for colorectal cancer Capecitabine is an oral prodrug of both doxifluridine and 5-fluorouracil. FDA approved use in breast and colorectal cancers. Hoffman LaRoche.
Coding
This drug should be coded
